Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine of USC, University of Southern, California2011 Zonal Avenue, HMR 801A, Los Angeles, CA, 90033-9141, USA.
Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Dig Dis Sci. 2023 May;68(5):2140-2148. doi: 10.1007/s10620-023-07867-8. Epub 2023 Mar 7.
Cirrhotic patients presenting with spontaneous bacterial peritonitis (SBP) have elevated risk of short-term mortality. While high Model for End-Stage Liver Disease-Sodium score (MELD-Na) and ascites culture yielding multi-drug resistance (MDR) bacteria are well established risk factors for further aggravating mortality, the impact of individual, causative microorganisms and their respective pathogenesis have not been previously investigated.
This is a retrospective study of 267 cirrhotic patients at two tertiary care hospitals undergoing paracentesis from January 2015 to January 2021 who presented with ascitic PMN count > 250 cellsmm. The primary outcome was SBP progression defined as death or liver transplantation within 1-month of paracentesis stratified by microorganism type.
Of 267 patients with SBP, the ascitic culture yielded causative microorganism in 88 cases [median age 57 years (IQR 52-64)]; 68% male; median MELD-Na 29 (IQR 23-35). The microbes isolated were E. coli (33%), Streptococcus (15%), Klebsiella (13%), Enterococcus (13%), Staphylococcus (9%) and others (18%); 41% were MDR. Cumulative incidence of SBP progression within 1-month was 91% (95% CI 67-100) for Klebsiella, 59% (95% CI 42-76) for E. coli, and 16% (95% CI 4-51) for Streptococcus. After adjusting for MELD-Na and MDR, risk of SBP progression remained elevated for Klebsiella (HR 2.07; 95% CI 0.98-4.24; p-value = 0.06) and decreased for Streptococcus (HR 0.28; 95% CI 0.06-1.21; p-value = 0.09) compared to all other bacteria.
Our study found Klebsiella-associated SBP had worse clinical outcomes while Streptococcus-associated SBP had the most favorable outcomes after accounting for MDR and MELD-Na. Thus, identification of the causative microorganism is crucial not only for optimizing the treatment but for prognostication.
患有自发性细菌性腹膜炎(SBP)的肝硬化患者有短期死亡的高风险。虽然高终末期肝病模型钠评分(MELD-Na)和腹水培养产生多药耐药(MDR)细菌是进一步加重死亡率的既定危险因素,但个体、致病微生物及其各自的发病机制的影响尚未得到先前的研究。
这是一项回顾性研究,纳入了 2015 年 1 月至 2021 年 1 月期间在两家三级护理医院接受经皮穿刺引流术的 267 例肝硬化患者,这些患者的腹水中性粒细胞计数>250 个细胞/mm。主要结局是 SBP 进展,定义为穿刺术后 1 个月内死亡或肝移植,根据微生物类型进行分层。
在 267 例 SBP 患者中,腹水培养出致病微生物的有 88 例[中位年龄 57 岁(IQR 52-64)];68%为男性;中位 MELD-Na 为 29(IQR 23-35)。分离出的微生物包括大肠杆菌(33%)、链球菌(15%)、克雷伯菌(13%)、肠球菌(13%)、葡萄球菌(9%)和其他(18%);41%为 MDR。1 个月内 SBP 进展的累积发生率为克雷伯菌 91%(95%CI 67-100),大肠杆菌 59%(95%CI 42-76),链球菌 16%(95%CI 4-51)。调整 MELD-Na 和 MDR 后,与所有其他细菌相比,SBP 进展的风险仍然较高的有克雷伯菌(HR 2.07;95%CI 0.98-4.24;p 值=0.06),而链球菌(HR 0.28;95%CI 0.06-1.21;p 值=0.09)的风险降低。
我们的研究发现,与所有其他细菌相比,克雷伯菌相关的 SBP 具有更差的临床结局,而链球菌相关的 SBP 具有最有利的结局,这考虑到了 MDR 和 MELD-Na。因此,确定致病微生物不仅对于优化治疗至关重要,对于预后也至关重要。